A resource for analyzing cancer protein data
The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data
This study is working on a new tool to help scientists better understand cancer by looking at protein markers in patient samples, which could lead to better treatments for everyone affected by cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10880347 on NIH RePORTER |
What this research studies
This research focuses on creating an integrated bioinformatics resource called The Cancer Proteome Atlas, which utilizes advanced techniques to analyze protein markers in cancer. By employing reverse-phase protein arrays, the project aims to assess a wide range of protein markers across numerous patient samples, helping to understand cancer mechanisms and treatment responses. The initiative will enhance data quality and expand analytic capabilities, ultimately benefiting the global cancer research community. Patients may indirectly benefit from improved cancer treatments developed through insights gained from this resource.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include cancer patients whose tumors can be analyzed for protein markers.
Not a fit: Patients with non-cancerous conditions or those not undergoing treatment for cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by providing critical insights into protein markers associated with cancer.
How similar studies have performed: Previous research utilizing similar proteomic approaches has shown success in enhancing our understanding of cancer biology and treatment responses.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Liang, Han — University of Tx Md Anderson Can Ctr
- Study coordinator: Liang, Han
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.